1. Home
  2. RELI vs CMND Comparison

RELI vs CMND Comparison

Compare RELI & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reliance Global Group Inc.

RELI

Reliance Global Group Inc.

HOLD

Current Price

$0.63

Market Cap

6.5M

Sector

Finance

ML Signal

HOLD

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

HOLD

Current Price

$2.70

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RELI
CMND
Founded
2013
2017
Country
United States
Canada
Employees
64
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
5.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RELI
CMND
Price
$0.63
$2.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1M
22.7M
Earning Date
11-06-2025
01-21-2026
Dividend Yield
4.53%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,115,995.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.61
$0.07
52 Week High
$5.11
$3.20

Technical Indicators

Market Signals
Indicator
RELI
CMND
Relative Strength Index (RSI) 36.84 91.22
Support Level $0.68 $0.07
Resistance Level $0.83 $0.13
Average True Range (ATR) 0.06 0.07
MACD 0.00 0.19
Stochastic Oscillator 2.57 82.57

Price Performance

Historical Comparison
RELI
CMND

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: